idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Medienpartner:
Wissenschaftsjahr


Teilen: 
16.04.2018 15:45

Cleavage Product of Alzheimer's Key Protein APP Stimulates Nerve Cell

Marietta Fuhrmann-Koch Kommunikation und Marketing
Universität Heidelberg

    A cleavage product of the Alzheimer's APP protein stimulates nerve cell communication and memory. The protein fragment, known as APPsα, has neuroprotective properties and acts as a signal molecule on other nerve cells. But how does it influence brain functions? An international research team led by Prof. Dr Ulrike Müller of Heidelberg University has gained new insights into the molecular mechanism underlying its physiological functions. The researchers discovered a receptor for APPsα, which paves the way for new treatment approaches for Alzheimer's.

    Press Release
    Heidelberg, 16 April 2018

    Cleavage Product of Alzheimer's Key Protein APP Stimulates Nerve Cell Communication
    Researchers discover receptor for the protein fragment APPsα mediating its physiological function

    A cleavage product of the Alzheimer's APP protein stimulates nerve cell communication and memory. The protein fragment, known as APPsα, has neuroprotective properties and acts as a signal molecule on other nerve cells. But how does it influence brain functions? An international research team led by Prof. Dr Ulrike Müller of Heidelberg University has gained new insights into the molecular mechanism underlying its physiological functions. The researchers discovered a receptor for APPsα, which paves the way for new treatment approaches for Alzheimer's.

    Alzheimer's disease (AD) is triggered by insoluble protein aggregates that are found as extracellular deposits in the brain of patients suffering from AD. The main component is the β-amyloid peptide (Aβ), which damages and eventually kills the nerve cells. This small peptide is a cleavage product of a substantially larger precursor protein, the amyloid precursor protein (APP). Alzheimer's was long assumed to be caused mainly by the overproduction of the β-amyloid peptide. "New studies show, however, that APPsα levels drop over the course of the disease. APPsα functions as an antagonist to the damaging Aβ," explains Prof. Müller. "In Alzheimer's, there is a misregulation in APP cleavage whereby too little APPsα is produced."

    To find out how the neuroprotective APPsα affects brain functions, the soluble protein fragment APPsα was introduced via viral "vectors" into the hippocampus of genetically modified mice. The hippocampus is a brain region that is considered as crucial for memory formation. The researchers were able to demonstrate that APPsα increases the number of synaptic contacts between nerve cells. "This was associated with more efficient nerve cell communication and improved memory in learning tests," states Ulrike Müller, professor of functional genomics at the Institute for Pharmacy and Molecular Biotechnology of Heidelberg University.

    Further electrophysiological experiments revealed that APPsα acts as a signaling molecule on the synaptic contacts of certain nerve cells. These synaptic contacts use the neurotransmitter acetylcholine, which is one of the most important messenger molecules for transmitting signals between nerve cells. The protein fragment APPsα enhances signal transmission by acetylcholine receptors and increases their natural receptivity. This is the first time that researchers have identified a receptor for APPsα in an animal model. "This paves the way for new options in Alzheimer's research, such as increasing the amount of APPsα in the brain," states Prof. Müller.

    Caption:
    Neuroprotective role of APPsα: A histological section through the hippocampus is depicted in the background. The red staining shows APPsα in neuronal cell bodies. The green staining shows the dendritic processes of nerve cells. Synaptic contacts between neurons are depicted as filled circles along the dendrites.
    Source: Max Richter, Müller research group

    Original publication:
    M.C. Richter, S. Ludewig, A. Winschel, T. Abel, C. Bold, L.R. Salzburger, S. Klein, K. Han, S. Weyer, A.K. Fritz, B. Laube, D.P. Wolfer, C.J. Buchholz, M. Korte and U.C. Müller: Distinct in vivo role of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. EMBO Journal e98335 (16 April 2018), doi: 10.15252/embj.201798335

    Contact:
    Prof. Dr Ulrike Müller
    Institute for Pharmacy and Molecular Biotechnology
    Phone +49 06221 54-6717
    u.mueller@urz.uni-hd.de

    Communications and Marketing
    Press Office, phone +49 6221 54-2311
    presse@rektorat.uni-heidelberg.de


    Weitere Informationen:

    http://www.ipmb.uni-heidelberg.de/bioinfo-fkt_gen/mueller


    Merkmale dieser Pressemitteilung:
    Journalisten
    Biologie
    überregional
    Forschungsergebnisse
    Englisch


    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).

    Cookies optimieren die Bereitstellung unserer Dienste. Durch das Weitersurfen auf idw-online.de erklären Sie sich mit der Verwendung von Cookies einverstanden. Datenschutzerklärung
    Okay